Varaico: Literature-Extracted Genetic Variants

Gene:GNAO1
Variant:p.G40R
Back to variants list

GNAO1

NM_020988.3:p.G40R

Associated Papers

Deciphering a mechanistic basis for the pathological effect of the GNAO1 E246K variant in neurodevelopmental disorder.

Sadiya I et al.

Bba Advances, 2026

Neuronal oscillatory imbalances in GNAO1-related disorders associated with disease severity.

Wang T et al.

Epilepsia, 2025

Dominant Gα mutations in human disease: unifying mechanisms and treatment strategies.

Katanaev VL et al.

Embo Molecular Medicine, 2025

40745211 (PubMed )
Supplement: 44321_2025_274_MOESM1_ESM.pdf

Identification of three novel GNAO1 variants in a Chinese cohort with GNAO1 encephalopathy: expanding the clinical and genetic spectrum.

Mei D et al.

Orphanet Journal of Rare Diseases, 2025

Novel Mutation at Cys225 in GNAO1-Associated Developmental and Epileptic Encephalopathies: Clinical, Molecular, and Pharmacological Profiling of Case Studies.

Larasati YA et al.

Medcomm, 2025

Zinc for GNAO1 encephalopathy: Preclinical profiling and a clinical case.

Larasati YA et al.

Med (new York, N.y.), 2025

Decoding GNAO1 mutations using Caenorhabditis elegans model system: past approaches and future prospectives.

Yadav S et al.

Frontiers in Cellular Neuroscience, 2025

Clinical and Molecular Profiling in GNAO1 Permits Phenotype-Genotype Correlation.

Lasa-Aranzasti A et al.

Movement Disorders : Official Journal of the Movement Disorder Society, 2024

Reference-informed prediction of alternative splicing and splicing-altering mutations from sequences.

Xu C et al.

Genome Research, 2024

39060028 (PubMed )
Supplement: Supplemental_Table_S8.xlsx › Table_S8

Neomorphic Gαo mutations gain interaction with Ric8 proteins in GNAO1 encephalopathies.

Solis GP et al.

The Journal of Clinical Investigation, 2024

Molecular annotation of G protein variants in a neurological disorder.

Knight KM et al.

Cell Reports, 2023

Genotype-phenotype correlation and treatment effects in young patients with GNAO1-associated disorders.

Thiel M et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2023

GNAO1-related neurodevelopmental disorder: Literature review and caregiver survey.

JoJo Yang QZ et al.

Epilepsy & Behavior Reports, 2023

Phenotypes in children with GNAO1 encephalopathy in China.

Li Y et al.

Frontiers in Pediatrics, 2023

Phenotypic Diversity in GNAO1 Patients: A Comprehensive Overview of Variants and Phenotypes.

Sáez González M et al.

Human Mutation, 2023

Gonadal mosaicism in GNAO1 causing neurodevelopmental disorder with involuntary movements; two additional variants.

Al Masseri Z et al.

Molecular Genetics and Metabolism Reports, 2022

Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia.

Di Rocco M et al.

Human Molecular Genetics, 2022

Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders.

Zhang Y et al.

Molecular Neurobiology, 2021

33860439 (PubMed )
Supplement: 12035_2021_2377_MOESM14_ESM.xlsx › NDD_probands__public_

Phenotypes of GNAO1 Variants in a Chinese Cohort.

Yang X et al.

Frontiers in Neurology, 2021

Clinically-relevant postzygotic mosaicism in parents and children with developmental disorders in trio exome sequencing data.

Wright CF et al.

Nature Communications, 2019

31278258 (PubMed )
Supplement: 41467_2019_11059_MOESM3_ESM.xlsx › Supplementary_Data1

Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy.

Takata A et al.

Nature Communications, 2019

31175295 (PubMed )
Supplement: 41467_2019_10482_MOESM5_ESM.xlsx › Supplementary_Data_2

Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.

Kelly M et al.

Epilepsia, 2019

Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes.

Feng H et al.

Plos One, 2019

Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing.

Bruun TUJ et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2018

Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnoses.

Bourchany A et al.

European Journal of Medical Genetics, 2017

Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations.

Feng H et al.

Neurology, 2017

GNAO1 encephalopathy: Broadening the phenotype and evaluating treatment and outcome.

Danti FR et al.

Neurology. Genetics, 2017

Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.

Menke LA et al.

Journal of Child Neurology, 2016

Targeted sequencing of 351 candidate genes for epileptic encephalopathy in a large cohort of patients.

de Kovel CG et al.

Molecular Genetics & Genomic Medicine, 2016

Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy.

Law CY et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry, 2015

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."